RGT 2.00% 25.5¢ argent biopharma limited

Ann: Retraction of Statement, page-2

  1. 13,851 Posts.
    lightbulb Created with Sketch. 2356
    Seriously? Talk about major and over the top exaggeration. MXC has become a minnow with an uncertain future.

    I doubt that the world sees the executives of MXC as "distinguished". Flogging off herbal supplements dies not qualify as a major player in the pharmaceutical industry.

    MGC Pharmaceuticals Ltd (LSE: MXC, ASX: MXC) is a prominent European pharmaceutical company
    with a strong commitment to creating accessible and ethically produced cutting-edge medicines. Our
    approach combines in-house research with innovative technologies, all aimed at discovering and
    producing treatments for currently unmet medical conditions.
    The company's founders and executives are distinguished figures in the global pharmaceutical
    industry.
    Our central business strategy revolves around the development and supply of innovative
    medicines, responding to the increasing demand in the medical markets of Europe, North America,
    and Australasia.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.